Mulmit

AGENUS INCAGENUS INC

AGEN Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31114,196,000-20,169,000-3,083,3920
2024-12-31103,463,000-120,475,000-232,271,210-10.59
2023-12-31156,314,000-159,549,000-257,437,042-13.75
2022-12-3198,024,000-179,427,000-15.64
2021-12-31295,665,00025,747,000-0.11

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-08-10ARMEN GARO HSee Remarks1,971,500
2026-08-05HARRISON THOMAS L50,000
2026-08-05Corvese Brian100,000
2026-08-05Wright Timothy50,000
2026-08-05O'Day Steven JChief Medical Officer100,000
2026-08-05Hirsch Susan B50,000
2026-08-05Buell JenniferSee Remarks200,000
2026-07-10ARMEN GARO HSee Remarks4,852
2026-07-01HARRISON THOMAS L8,547
2026-07-01Wright Timothy2,268
2026-06-26ARMEN GARO HSee Remarks5,364
2026-06-12ARMEN GARO HSee Remarks4,925

8-K events

FiledItems
2026-08-18Entry into a material agreement · Creation of a direct financial obligation · Unregistered sales of equity securities
2026-08-13Officer or director change
2026-08-11Officer or director change
2026-08-06Results of operations
2026-07-13Entry into a material agreement · Unregistered sales of equity securities · Regulation FD disclosure · Other events · Financial statements and exhibits
2026-07-06Entry into a material agreement
2026-06-23Submission of matters to a vote
2026-05-15Officer or director change
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.